科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
专利缴费
专利查询
未登录
返回
期刊详情
Expert Opinion on Emerging Drugs
IF
2.7
论文数
50
被引数
897
相关解读
0
订阅
期刊论文
50
相关解读
0
期刊论文
50
发表时间
发表时间
IF
被引数
PROTAC degraders for lymphoid malignancies — current status and future directions
PROTAC降解剂用于淋巴性恶性疾病——当前状态和未来方向
Expert Opinion on Emerging Drugs
IF
2.7
2026-10-24
0
PRE
AI
Anna Wolska-Washer; Tadeusz Robak
分享
收藏
Emerging therapies for pericarditis: from anti-IL-1 agents to novel therapeutic options
心包炎新兴疗法:从抗白介素-1药物到新型治疗选择
Expert Opinion on Emerging Drugs
IF
2.7
2026-10-03
0
OA
AI
Massimo Imazio; Valentino Collini; Francesco Venturelli; Maria Cristina Tomat; Giulio Savonitto; Davide Stolfo
分享
收藏
Emerging drugs for diabetic macular edema: an update
糖尿病黄斑水肿的新兴药物:现状更新
Expert Opinion on Emerging Drugs
IF
2.7
2026-10-01
0
PRE
AI
Charles Zhang; Sinan Ersan; Abdullah Virk; Alexander E. Higgins; Ingrid U. Scott; Harry W. Flynn Jr
分享
收藏
Targeted oral peptide therapy for inflammatory bowel disease: focus on the IL-23 receptor antagonist icotrokinra
靶向口服多肽疗法治疗炎症性肠病:聚焦于IL-23受体拮抗剂icotrokinra
Expert Opinion on Emerging Drugs
IF
2.7
2026-09-28
0
OA
AI
Daniele Noviello; Flavio Caprioli; Nurulamin M. Noor
分享
收藏
Emerging drugs for the treatment of gastrointestinal stromal tumors: a spotlight on bezuclastinib and the evolving treatment landscape
胃肠道间质瘤的治疗新药:聚焦贝祖卡替尼和不断演变的治疗格局
Expert Opinion on Emerging Drugs
IF
2.7
2026-09-26
0
OA
AI
Javier Pozas; Andrea Napolitano; Robin L Jones
分享
收藏
Recent advances in hidradenitis suppurativa therapeutics: a focus on existing and future medical therapeutics
Hidradenitis suppurativa治疗领域的最新进展:聚焦现有及未来医学治疗手段
Expert Opinion on Emerging Drugs
IF
2.7
2026-09-09
0
PRE
AI
Camila R. Marquez; Aditya Joshi; Lauren Gawey; Stacey N. Giuffre; Crystal Khem; Jennifer L. Hsiao; Vivian Y. Shi
分享
收藏
Claudin-6 as a potential target in the treatment of ovarian cancer: a review of emerging drugs
Claudin-6作为卵巢癌治疗中的潜在靶点:新兴药物的综述
Expert Opinion on Emerging Drugs
IF
2.7
2026-07-26
0
PRE
AI
Sarah Ottum; Namrata Sethi; Cem Demirkiran; Orazio De Tommasi; Alessandro D. Santin
分享
收藏
Drug discovery progress in targeting the renin–angiotensin–aldosterone system for heart failure
心力衰竭靶向肾素-血管紧张素-醛固酮系统药物发现进展
Expert Opinion on Emerging Drugs
IF
2.7
2026-07-21
0
PRE
AI
Diksha Choudhary; Nisha Bansal; Bhupinder Kumar
分享
收藏
Emerging biological drugs for the treatment of patients with metastatic HER2+ gastroesophageal adenocarcinomas
用于治疗HER2阳性转移性胃食管腺癌患者的新兴生物药物
Expert Opinion on Emerging Drugs
IF
2.7
2026-07-20
0
PRE
AI
Jane E. Rogers; Ashley Horak; Alicia Kroll; Jaffer A. Ajani
分享
收藏
At the forefront of gene-based therapies in Dravet syndrome
德瓦氏综合征基因疗法的前沿
Expert Opinion on Emerging Drugs
IF
2.7
2026-07-08
0
OA
AI
Antonella Riva; Sara Di Gioacchino; Greta Volpedo; Beatrice Risso; Antonella De Lillo; Federico Zara; Antonio Falace; Pasquale Striano
分享
收藏
Sigma 1 receptor agonists: the new trend or an emerging therapeutic option?
Sigma 1受体激动剂:是新的趋势还是新兴的治疗选择?
Expert Opinion on Emerging Drugs
IF
2.7
2026-06-29
0
OA
AI
Tangui Maurice
分享
收藏
Obefazimod (ABX464) for moderate-to-severe Crohn’s disease: clinical development of a novel oral therapeutic approach
奥贝非齐莫德(ABX464)治疗中重度克罗恩病:一种新型口服治疗方法的临床开发
Expert Opinion on Emerging Drugs
IF
2.7
2026-06-29
0
OA
AI
Sailish Honap; Axel Dignass; Vipul Jairath; Fernando Magro; Silvio Danese; Laurent Peyrin-Biroulet
分享
收藏
Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer’s disease
评估以淀粉样蛋白-β为中心的新兴药物对阿尔茨海默病的治疗效果
Expert Opinion on Emerging Drugs
IF
2.7
2026-06-22
0
PRE
AI
Madia Lozupone; Vittorio Dibello; Rodolfo Sardone; Roberta Zupo; Fabio Castellana; Ilaria Bortone; Luisa Lampignano; Michela Di Matteo; Giuseppe Moramarco; Flora Dellegrazie; Antonio Daniele; Vincenzo Solfrizzi; Francesco Panza
分享
收藏
Emerging treatment options for chronic obstructive pulmonary disease: a look into 2026 and beyond
慢性阻塞性肺疾病的新兴治疗选择:展望2026年及未来
Expert Opinion on Emerging Drugs
IF
2.7
2026-06-22
0
PRE
AI
Carolyn J. Wang; Clarus Leung; Don D. Sin
分享
收藏
Acute management of adult MOG antibody–associated disease: therapeutic choices and clinical outcomes
成人MOG抗体相关疾病的急性期管理:治疗选择与临床结局
Expert Opinion on Emerging Drugs
IF
2.7
2026-06-18
0
OA
AI
Edgar Carnero Contentti; Eoin P. Flanagan; Ethel Ciampi
分享
收藏
Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies
月经过度性偏头痛的治疗:超越曲坦类药物,CGRP靶向疗法的兴起角色
Expert Opinion on Emerging Drugs
IF
2.7
2026-06-16
0
OA
AI
Lanfranco Pellesi; Damiana Scuteri; Andrea Burgalassi; Alberto Chiarugi; Paolo Martelletti
分享
收藏
Emerging small molecules for ulcerative colitis: clinical advancements and trial insights
新兴小分子在溃疡性结肠炎中的应用:临床进展与试验见解
Expert Opinion on Emerging Drugs
IF
2.7
2026-06-07
0
PRE
AI
Cristina Lanzotti; Fabrizio Fanizzi; Ferdinando D’Amico; Alessandra Zilli; Federica Furfaro; Mariangela Allocca; Virginia Solitano; Clelia Cicerone; Sara Massironi; Tommaso Lorenzo Parigi; Laurent Peyrin-Biroulet; Silvio Danese
分享
收藏
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer
胆管癌治疗中的新兴claudin-18.2拮抗剂
Expert Opinion on Emerging Drugs
IF
2.7
2026-06-05
0
PRE
AI
Daniel Neureiter; Dino Bekric; Christian Mayr; Tobias Kiesslich; Matthias Ocker
分享
收藏
Emerging pharmacotherapies in Gaucher disease
戈谢病中的新兴药物治疗
Expert Opinion on Emerging Drugs
IF
2.7
2026-05-19
0
OA
AI
Gregory M. Pastores
分享
收藏
Potassium channel agonists emerging as treatment options for focal epilepsy: are we breaking new ground?
钾通道激动剂作为治疗局灶性癫痫的选项正在兴起:我们是否在开辟新领域?
Expert Opinion on Emerging Drugs
IF
2.7
2026-05-19
0
PRE
AI
Cristiana Pelorosso; Simona Balestrini; Renzo Guerrini
分享
收藏